NCT01163448 Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer Status WITHDRAWN Phase PHASE1
NCT01161563 Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration Status COMPLETED Phase PHASE4
NCT01155791 Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer Status TERMINATED Phase PHASE1
NCT01148069 Surgery Combined With Intensity Modulated Radiation Therapy - Image-Guided Radiation Therapy (IMRT-IGRT) in Locally-advanced Prostate Cancers Status COMPLETED Phase PHASE2
NCT01147965 QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA Status COMPLETED Phase PHASE1/PHASE2
NCT01146340 Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01144897 PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy Status COMPLETED Phase PHASE1
NCT01140373 Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01138527 Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach Status COMPLETED Phase N/A
NCT01136226 Evaluate Recovery of Testosterone for Patients Using Eligard Status COMPLETED Phase PHASE4
NCT01132599 Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer Status WITHDRAWN Phase PHASE2
NCT01132404 Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 Status TERMINATED Phase PHASE1/PHASE2
NCT01120262 S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin Status COMPLETED Phase N/A
NCT01119118 ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer Status TERMINATED Phase PHASE2
NCT01118741 Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA) Status COMPLETED Phase NA